{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:21:14Z","timestamp":1791195674077,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.nmd.2013.02.008","type":"journal-article","created":{"date-parts":[[2013,3,7]],"date-time":"2013-03-07T16:06:41Z","timestamp":1362672401000},"page":"413-417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Performance of individual items of the quantitative myasthenia gravis score"],"prefix":"10.1016","volume":"23","author":[{"given":"T. Carolina","family":"Barnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Bril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.nmd.2013.02.008_b0005","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/WNL.33.10.1316","article-title":"Myasthenia gravis: long-term correlation of binding and bungarotoxin blocking antibodies against acetylcholine receptors with changes in disease severity","volume":"33","author":"Besinger","year":"1983","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.nmd.2013.02.008_b0010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM198703193161205","article-title":"Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis","volume":"316","author":"Tindall","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2013.02.008_b0015","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1749-6632.1993.tb22937.x","article-title":"A clinical therapeutic trial of cyclosporine in myasthenia gravis","volume":"681","author":"Tindall","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nmd.2013.02.008_b0020","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann N Y Acad Sci."},{"issue":"4","key":"10.1016\/j.nmd.2013.02.008_b0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/CND.0b013e31824619d5","article-title":"The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers","volume":"13","author":"Barnett","year":"2012","journal-title":"J Clin Neuromuscul Dis"},{"issue":"11","key":"10.1016\/j.nmd.2013.02.008_b0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1212\/01.wnl.0000256698.69121.45","article-title":"IV Immunoglobulin in patients with myasthenia gravis: a randomized controlled trial","volume":"68","author":"Zinman","year":"2007","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.nmd.2013.02.008_b0035","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1212\/WNL.0b013e31821e5505","article-title":"Comparison of IVIg and PLEX in patients with myasthenia gravis","volume":"76","author":"Barth","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nmd.2013.02.008_b0040","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/01.wnl.0000312373.67493.7f","article-title":"A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis","volume":"71","author":"Muscle Study Group","year":"2008","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nmd.2013.02.008_b0045","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","article-title":"An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis","volume":"71","author":"Sanders","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nmd.2013.02.008_b0050","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/mus.21142","article-title":"Comparison of outcome measures from a trial of Mycophenolate mofetil in myasthenia gravis","volume":"38","author":"Wolfe","year":"2008","journal-title":"Muscle Nerve"},{"issue":"19","key":"10.1016\/j.nmd.2013.02.008_b0055","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.0b013e3181dd43bf","article-title":"Ephedrine treatment in congenital myasthenic syndrome due to mutations in DOK7","volume":"74","author":"Lashley","year":"2010","journal-title":"Neurology"},{"issue":"47","key":"10.1016\/j.nmd.2013.02.008_b0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1529-8027.2011.00318.x","article-title":"On behalf of the PeiNomS Study group. Revised normative values for grip strength with the Jamar dynamometer","volume":"16","author":"Peters","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nmd.2013.02.008_b0065","series-title":"R: a language and environment for statistical computing","author":"Team","year":"2011"},{"issue":"2","key":"10.1016\/j.nmd.2013.02.008_b0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1545968308315046","article-title":"Fatigue versus activity-dependent fatigability in patients with central or peripheral motor impairments","volume":"22","author":"Dobkin","year":"2008","journal-title":"Neurorehabil Neural Repair"},{"issue":"2","key":"10.1016\/j.nmd.2013.02.008_b0075","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ejcnurse.2005.10.001","article-title":"Reliability of clinical muscular endurance tests in patients with chronic heart failure","volume":"5","author":"Cider","year":"2006","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"5","key":"10.1016\/j.nmd.2013.02.008_b0080","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jmpt.2008.04.010","article-title":"Reliability of isometric muscle endurance tests in subjects with postural neck pain","volume":"31","author":"Edmondston","year":"2008","journal-title":"J Manipulative Physiol Ther"},{"issue":"6","key":"10.1016\/j.nmd.2013.02.008_b0085","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/mus.21185","article-title":"The Muscle Study Group. Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite","volume":"38","author":"Burns","year":"2008","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.nmd.2013.02.008_b0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2340\/165019771995109117","article-title":"Isometric muscle strength and muscular endurance in normal persons aged between 17 and 70 years","volume":"27","author":"B\u00e4ckman","year":"1995","journal-title":"Scand J Rehabil Med"},{"issue":"4","key":"10.1016\/j.nmd.2013.02.008_b0095","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.math.2010.12.005","article-title":"Endurance and fatigue characteristics of the neck flexor and extensor muscles during isometric tests in patients with postural neck pain","volume":"16","author":"Edmondston","year":"2011","journal-title":"Manual Therapy"},{"issue":"3","key":"10.1016\/j.nmd.2013.02.008_b0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/mus.21880","article-title":"The oculobulbar facial respiratory score is a tool to assess bulbar function in myasthenia gravis patients","volume":"43","author":"Farrugia","year":"2011","journal-title":"Muscle Nerve"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613000643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896613000643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:01:07Z","timestamp":1760774467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896613000643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0960896613000643"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2013.02.008","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of individual items of the quantitative myasthenia gravis score","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2013.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}